POGGESI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 4.035
EU - Europa 2.056
AS - Asia 414
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
OC - Oceania 1
Totale 6.512
Nazione #
US - Stati Uniti d'America 4.024
PL - Polonia 538
IT - Italia 444
IE - Irlanda 379
SE - Svezia 332
HK - Hong Kong 170
CN - Cina 79
FI - Finlandia 75
DE - Germania 73
GB - Regno Unito 70
JO - Giordania 58
UA - Ucraina 53
SG - Singapore 45
RU - Federazione Russa 44
TR - Turchia 38
VN - Vietnam 16
ES - Italia 12
FR - Francia 12
BE - Belgio 11
CA - Canada 11
NL - Olanda 6
MK - Macedonia 5
IN - India 4
EU - Europa 2
PH - Filippine 2
UZ - Uzbekistan 2
BR - Brasile 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CM - Camerun 1
NZ - Nuova Zelanda 1
SC - Seychelles 1
Totale 6.512
Città #
Fairfield 704
Warsaw 538
Dublin 379
Woodbridge 342
Chandler 319
Ashburn 315
Cambridge 272
Seattle 270
Houston 265
Wilmington 224
Ann Arbor 136
Altamura 130
Lawrence 130
Princeton 111
Jacksonville 103
Hong Kong 95
Florence 85
Boston 59
Medford 59
Beijing 58
Buffalo 58
Boardman 44
San Diego 38
Izmir 35
Moscow 27
Falls Church 21
New York 20
Hillsboro 18
London 14
Norwalk 14
Shanghai 14
Singapore 14
Dong Ket 12
Rome 12
Andover 11
Barcelona 11
Brussels 11
Toronto 11
Forlì 9
Milan 9
Dearborn 8
Kent 7
Los Angeles 7
Siena 7
Detroit 6
Arkhangelsk 5
Redmond 5
Redwood City 5
Serra 5
Phoenix 4
San Salvatore 4
Auburn Hills 3
Chengdu 3
Fiesole 3
Hounslow 3
Munich 3
Ponte Buggianese 3
Treviso 3
Washington 3
West Jordan 3
Anzio 2
Arezzo 2
Bremen 2
Carmignano di Brenta 2
Catania 2
Chicago 2
Frankfurt Am Main 2
Gallarate 2
Gavirate 2
Kilburn 2
Lanciano 2
Mcallen 2
Medolla 2
Monteroni d'Arbia 2
Mountain View 2
Nürnberg 2
Padova 2
Paris 2
Pianoro 2
Pisa 2
Positano 2
Pune 2
Romainville 2
Verona 2
Verrua Savoia 2
Wuhan 2
Ancona 1
Asciano 1
Auckland 1
Bergamo 1
Bern 1
Besana In Brianza 1
Campi Bisenzio 1
Castelfiorentino 1
Cedar Knolls 1
Chennai 1
Chiswick 1
Clifton 1
Corsico 1
Fremont 1
Totale 5.153
Nome #
Prediction of impaired performance in Trail Making Test in MCI patients with small vessel disease using DTI data 213
White matter microstructural damage in small vessel disease is associated with montreal cognitive assessment but not with mini mental state examination performances: vascular mild cognitive impairment tuscany study. 207
Incidenza di ictus e leucoaraiosi quali fattori predittivi indipendenti di transizione verso la disabilità: lo studio europeo LADIS (Leukoaraiosis And DISability) 151
Cerebral small vessel disease and systemic arteriopathy in intracranial arterial dolichoectasia patients 136
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 129
Risk and Determinants of Dementia in Patients with Mild Cognitive Impairment and Brain Subcortical Vascular Changes: A Study of Clinical, Neuroimaging, and Biological Markers-The VMCI-Tuscany Study: Rationale, Design, and Methodology. 128
Role of biological markers for cerebral bleeding risk STRATification in patients with atrial fibrillation on oral anticoagulants for primary or secondary prevention of ischemic stroke (Strat-AF study): Study design and methodology 125
Reperfusion Injury after ischemic Stroke Study (RISKS): Single-centre (Florence, Italy), prospective observational protocol study 123
The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study 115
Stroke unit care in clinical practice: an observational study in the Florence center of the European Registers of Stroke (EROS) Project. 105
Diffusion Tensor Imaging to Map Brain Microstructural Changes in CADASIL 104
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study 103
Circulating Biomarkers in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients 101
Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort 90
Development and Psychometric Properties of a Neuropsychological Battery for Mild Cognitive Impairment with Small Vessel Disease: The VMCI-Tuscany Study. 87
Physical Activity Prevents Progression for Cognitive Impairment and Vascular Dementia: Results From the LADIS (Leukoaraiosis and Disability) Study. 87
A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient 87
Letter by Pescini et al Regarding Article, "Peripheral Artery Disease as a Manifestation of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) and Practical Implications". 81
Association of gait and balance disorders with age-related white matter changes: the LADIS study 79
Familial cerebral cavernous malformation: report of a further Italian family 78
Diffusion changes predict cognitive and functional outcome: the LADIS study. 78
Cognitive decline and dementia related to cerebrovascular diseases: some evidence and concepts 77
Fractal dimension of cerebral white matter: A consistent feature for prediction of the cognitive performance in patients with small vessel disease and mild cognitive impairment 76
The Florence VAS-COG clinic: a model for the care of patients with cognitive and behavioral disturbances consequent to cerebrovascular diseases. 76
Facial Affect Recognition in CADASIL Patients. 75
Factors predicting the Montreal cognitive assessment (MoCA) applicability and performances in a stroke unit. 75
The rehabilitation of attention in patients with mild cognitive impairment and brain subcortical vascular changes using the Attention Process Training-II. The RehAtt Study: rationale, design and methodology 75
Influence of vascular risk factors and neuropsychological profile on functional performances in CADASIL: results from the MIcrovascular LEukoencephalopathy Study (MILES). 74
Assessing mental flexibility: neuroanatomical and neuropsychological correlates of the Trail Making Test in elderly people. 73
Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. 73
Multimodal MRI classification in vascular mild cognitive impairment 71
White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study. 71
Mild cognitive impairment etiologic subtyping using pragmatic and conventional criteria: preliminary experience in the Florence VAS-COG clinic. 71
Psychiatric disturbances in CADASIL: a brief review 69
Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview 69
Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. 69
Physical activity in the elderly is associated with improved executive function and processing speed: The LADIS Study 69
Confirmatory factor analysis of the Neuropsychological Assessment Battery of the LADIS study: a longitudinal analysis. 68
2001-2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease? 67
Post-stroke dementia and cognitive impairment. 67
A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient 66
Deep frontal and periventricular age-related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls - cross-sectional results from the LADIS study. 66
Self-perceived memory complaints predict progression to Alzheimer disease. The LADIS study. 65
Age-related white matter changes predict hidden global functioning impairment. 64
Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment. 64
Thrombolysis in acute stroke patients with cerebral small vessel disease 64
Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. 63
The VAS-COG clinic: an out-patient service for patients with cognitive and behavioral consequences of cerebrovascular diseases. 61
Stroke occurrence and leukoaraiosis are independently associated with transition to disability: the LADIS (Leukoaraiosis and disability) Study. 61
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. 61
Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review 61
Impact of cerebral white matter changes on functionality in older adults: An overview of the LADIS Study results and future directions 61
Comparison between Ischemic and Hemorrhagic Strokes in Functional Outcome at Discharge from an Intensive Rehabilitation Hospital 61
Age-related white matter changes and heart failure. The LADIS (Leukoaraiosis And DISability) Study. 60
White matter changes and late-life depressive symptoms: longitudinal study 60
Gender differences in post-stroke functional outcome at discharge from an intensive rehabilitation hospital 60
Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study 60
Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study. 59
Calcium channel blockers and stroke prevention 58
The role of white matter hyperintensities and medial temporal lobe atrophy in age-related executive dysfunctioning. 56
Atrial Fibrillation and Cognition: Epidemiological Data and Possible Mechanisms 56
Is type 2 diabetes related to leukoaraiosis? An updated review 56
White Matter Lesion Progression in LADIS: Frequency, Clinical Effects, and Sample Size Calculations. 55
Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: the LADIS study. 55
Neurological abnormalities predict disability: the LADIS (Leukoaraiosis And DISability) study 55
Age-related white matter changes as independent predictors of disability in the elderly. The LADIS (Leukoaraiosis and disability) Project: evidence from the first year follow-up. 55
Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. 55
Alterazioni diffuse della sostanza bianca cerebrale ed aumento del rischio di disabilità nei soggetti anziani. Studio Europeo LADIS (Leukoaraiosis And DISability): evidenze dal primo anno di follow-up. 54
CEREBRAL WHITE MATTER CHANGES ARE ASSOCIATED WITH ABNORMALITIES ON NEUROLOGICAL EXAMINATION IN NON-DISABLED ELDERLY: THE LADIS STUDY. 54
Association Between Motor and Cognitive Performances in Elderly With Atrial Fibrillation: Strat-AF Study 54
Investigations in primary care. 52
CALCIUM CHANNEL BLOCKERS AND STROKE. 51
Deterioration of gait and balance over time: the effects of age-related white matter change--the LADIS study. 49
Cardiac calcified amorphous tumor as a rare cause of ischemic stroke: Clinical case 49
Urinary disturbances in elderly non-disabled subjects with cerebral age-related white matter changes. The LADIS (Leukoaraiosis And DISability) Study. 47
Assessment of cerebrovascular disease with computed tomography in COVID-19 patients: correlation of a novel specific visual score with increased mortality risk 47
Association of nimodipine and choline alphoscerate in the treatment of cognitive impairment in patients with cerebral small vessel disease: study protocol for a randomized placebo-controlled trial—the CONIVaD trial 47
Neuropsychiatric aspects of vascular cognitive impairment 46
Predictors of Function, Activity, and Participation of Stroke Patients Undergoing Intensive Rehabilitation: A Multicenter Prospective Observational Study Protocol 46
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 45
The relation between white-matter lesions and cognition. 44
Blood–brain barrier leakage and hemorrhagic transformation: The Reperfusion Injury in Ischemic StroKe (RISK) study 44
Relevance of brain lesion location for cognition in vascular mild cognitive impairment 43
Cortical activation correlates of leuko-araiosis. A fMRI and DTI study 40
Critical issue on the extinction and inattention subtest of NIHSS scale: an analysis on post-acute stroke patients attending inpatient rehabilitation 38
Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial 36
Can CHA2DS2-VASc and HAS-BLED Foresee the Presence of Cerebral Microbleeds, Lacunar and Non-Lacunar Infarcts in Elderly Patients With Atrial Fibrillation? Data From Strat-AF Study 31
Detection of subclinical atrial fibrillation after cryptogenic stroke using implantable cardiac monitors 29
Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study 27
Neurology: the near future 26
The use of CT in dementia. 25
Cognitive phenotypes and factors associated with cognitive decline in a cohort of older patients with atrial fibrillation: The Strat-AF study 20
Resilience and Resistance in Aging and Alzheimer Disease: Another Step to Fill the Gap Between Clinicians and Researchers 20
Effects of Aging and Hypertension on Cerebrovascular Reactivity, Endothelial Function and Cognitive Performance (Fair Culture Test) 19
Medial temporal lobe atrophy relates more strongly to sleep-wake rhythm fragmentation than to age or any other known risk 18
Resting state fMRI regional homogeneity correlates with cognition measures in subcortical vascular cognitive impairment 16
Longitudinal changes in MoCA performances in patients with mild cognitive impairment and small vessel disease. Results from the VMCI-Tuscany Study 16
Max-ICH score: Can it prevent self-fulfilling prophecy in ICH? 15
Physio-pathology of large vessels in vascular dementia. In “Vascular cognitive impairment in clinical practice” 14
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 13
Totale 6.565
Categoria #
all - tutte 21.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019542 0 0 0 0 0 0 0 0 0 0 296 246
2019/20201.442 126 85 36 119 166 174 173 180 156 97 98 32
2020/2021882 74 70 48 81 35 107 35 68 111 126 61 66
2021/2022719 27 71 65 15 24 46 26 65 30 28 122 200
2022/20231.665 171 357 51 89 119 267 243 82 178 9 81 18
2023/2024593 22 82 115 36 62 61 24 120 22 42 7 0
Totale 6.629